Azienda Ospedaliera Sant'Andrea; UOC Neurologia
About Azienda Ospedaliera Sant'Andrea; UOC Neurologia
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Azienda Ospedaliera Sant'Andrea; UOC Neurologia
During the past decade, Azienda Ospedaliera Sant'Andrea; UOC Neurologia conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 1 clinical trials were completed, i.e. on
average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
2013-04-01
2030-01-01
Active, not recruiting
1,900
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery
2013-12-13
Active, not recruiting
1,473
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
2013-12-23
2023-07-01
Active, not recruiting
488
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
2014-07-22
2023-12-31
Active, not recruiting
280
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Azienda Ospedaliera Sant'Andrea; UOC Neurologia"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Azienda Ospedaliera Sant'Andrea; UOC Neurologia
According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Sant'Andrea; UOC Neurologia" are
"Multiple Sclerosis" (4 trials), "Alzheimer's Disease" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Generalized Myasthenia Gravis" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera Sant'Andrea; UOC Neurologia" in a lesser frequency.
Clinical Trials Intervention Types at Azienda Ospedaliera Sant'Andrea; UOC Neurologia
Most popular intervention types in "Azienda Ospedaliera Sant'Andrea; UOC Neurologia" are "Drug" (13 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (8 trials), "Placebo" (5 trials), "Antihistamine" (1 trials), "Desloratadine given orally" (1 trials) and "Dexamethasone given orally" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Azienda Ospedaliera Sant'Andrea; UOC Neurologia
The vast majority of trials in "Azienda Ospedaliera Sant'Andrea; UOC Neurologia" are
14 trials for "All" genders.
Clinical Trials Status at Azienda Ospedaliera Sant'Andrea; UOC Neurologia
Currently, there are NaN active trials in "Azienda Ospedaliera Sant'Andrea; UOC Neurologia".
undefined are not yet recruiting,
7 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Azienda Ospedaliera Sant'Andrea; UOC Neurologia,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Azienda Ospedaliera Sant'Andrea; UOC Neurologia, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 12 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".